The neuroprotective effects of ketone bodies rely on alternative brain energy fuel recovery in lipid biosynthesis and influence on neuronal excitability [35,36], although the exact mechanism(s) of action of KD along with biochemical changes that are KD-related are still unknown, and KD is not fully effective in all GLUT1-DS patients [7]. Here, SLC2A1 is linked to Dravet syndrome.